Effects of enhanced external counterpulsation (EECP) on myocardial perfusion

American Journal of Therapeutics

Volumn 14, Issue 6, 2007, Pages 519-523

  Arora, Rohit R ^a,c   Bergmann, Steven ^b  

^a ROSALIND FRANKLIN UNIVERSITY OF MEDICINE AND SCIENCE   (United States)

^b BETH ISRAEL MEDICAL CENTER   (United States)

^c The Chicago Medical College   (United States)

Author keywords

Enhanced External Counterpulsation; Myocardial perfusion

Indexed keywords

AMMONIA N 13; DIPYRIDAMOLE;

ADULT; AGED; ANGINA PECTORIS; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; COMPARTMENT MODEL; CONTINUOUS INFUSION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY DISEASE; COUNTERPULSATION; ENHANCED EXTERNAL COUNTERPULSATION; FEMALE; HEART MUSCLE PERFUSION; HUMAN; MALE; MULTICENTER STUDY; NON INVASIVE PROCEDURE; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME;

AGED; ANGINA PECTORIS; BLOOD PRESSURE; CORONARY CIRCULATION; COUNTERPULSATION; FEMALE; HEART RATE; HUMANS; MALE; MIDDLE AGED; POSITRON-EMISSION TOMOGRAPHY;

EID: 37349091158     PISSN: 10752765     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.mjt.0000249890.00290.30     Document Type: Article

References (10)

1. Arora RR, Nest NW, Chou TM, et al. Results of the Multicenter Study of Enhanced External Counterpulsation (MUST-EECP): EECP reduces anginal episodes and exercise-induced myocardial ischemic. J Am Coll Cardiol. 1999;33:1833-1840.
2. Lawson WE, Hui JCK, Soroff HS, et al. Efficacy of enhanced external counterpulsation in the treatment of anginal pectoris. Am J Cardiol. 1992;70:859-862.
3. Lawson WE, Hui JCK, Zheng ZS, et al. Three-year sustained benefit from enhanced external counterpulsation in chronic anginal pectoris. Am J Cardiol. 1966;75:840-841.
4. Lawson WE, Hui JCK, Zheng ZS, et al. Can angiographic findings predict which coronary patients will benefit from enhanced external counterpulsation? Am J Cardiol. 1996;77:1107-1109.
5. Lawson WE, Hui JCK, Zheng ZS, et al. Improved exercise tolerance following enhanced external counterpulsation: cardiac or peripheral effect? Cardiology. 1996;87:1-5.
6. Lawson WE, Hui J, Burger L, et al. Five-year follow-up of morbidity and mortality in 33 angina patients treated with enhanced external counterpulsation [abstract]. J Invest Med. 1997;45:212A.
7. Lawson WE, Hui JCK, Burger L, et al. Triple vessel disease patients benefit from enhanced external counterpulsation despite stenotic grafts [abstract]. J Invest Med. 1997;45:214A.
8. Kuhle WG, Porenta G, Huang SC, et al. Quantification of regional myocardial blood flow using 13N-ammonia and reoriented dynamic positron emission tomographic imaging [abstract]. 1992;86:1004-17.
9. Hickey KT, Sciacca RR, Chou RL, et al. An improved model for the measurement of myocardial perfusion in human beings using N-13 ammonia [abstract]. J Nuclear Cardiol. 2005;12:311-317.
10. Rosenspire KC, Schwaiger M, Mangner TJ, et al. Metabolic fate of (13N) ammonia in human and canine blood. J Nuclear Med. 1990;31:163-167.